Breast implant-associated anaplastic large cell lymphoma: A systematic review of the literature and mini-meta analysis

Current Hematologic Malignancy Reports

Volumn 8, Issue 3, 2013, Pages 196-210

  Thompson, Philip A ^a   Prince, H Miles ^b,c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anaplastic; Breast; Effusion; Implant; Large cell; Lymphoma; Meta analysis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD2 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CELL MARKER; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; SYNDECAN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST LESION; CANCER CELL CULTURE; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION; EFFUSION; ESTHETIC SURGERY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; IMPLANT CAPSULAR CONTRACTURE; LARGE CELL LYMPHOMA; LONG TERM SURVIVAL; MASTECTOMY; META ANALYSIS; NODAL MARGINAL ZONE LYMPHOMA; PERIPHERAL LYMPHOCYTE; PERIPHERAL T CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PROTEIN EXPRESSION; SILICONE BREAST IMPLANT; SILICONE PROSTHESIS; SYSTEMATIC REVIEW; TREATMENT RESPONSE; WALDENSTROEM MACROGLOBULINEMIA; BREAST AUGMENTATION; BREAST IMPLANT; BREAST NEOPLASMS; FEMALE; LYMPHOMA, LARGE-CELL, ANAPLASTIC; PATHOLOGY; RISK FACTOR;

BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; RISK FACTORS;

EID: 84883861696     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-013-0164-3     Document Type: Article

References (53)

1. FDA. FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants. 2011 [16/2/2013]; Available from: http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm240000.htm.
2. • de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbe E, Casparie MK, et al. Anaplastic large cell lymphoma in women with breast implants. JAMA. 2008;300(17):2030-5. [Research Support, Non-U.S. Gov't]. One of few available epidemiological studies suggesting an association between breast implants and ALCL.
3. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009;123(3):790-3 [Review].
4. Brisson J, Holowaty EJ, Villeneuve PJ, Xie L, Ugnat AM, Latulippe L, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer. 2006;118(11):2854-62 [Research Support, Non-U.S. Gov't].
5. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol. 2001;11(4):248-56 [Multicenter Study].
6. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg. 2007;119(7):1987-92 [Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
7. Lipworth L, Tarone RE, Friis S, Ye W, Olsen JH, Nyren O, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer. 2009;124(2):490-3 [Research Support, Non-U.S. Gov't].
8. Pukkala E, Boice Jr JD, Hovi SL, Hemminki E, Asko-Seljavaara S, Keskimaki I, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants. 2002;12(4):271-9 [Research Support, Non-U.S. Gov't].
9. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
10. Falini B, Martelli MP. Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. Haematologica. 2009;94(7):897-900 [Comment Editorial].
11. Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93(11):3913-21 [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
12. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111(12):5496-504 [Multicenter Study].
13. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85 [Review].
14. Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Blood. 2011;118(15):4024-35 [Research Support, Non-U.S. Gov't Review].
15. Barista I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozisik Y, et al. Primary breast lymphomas-a retrospective analysis of twelve cases. Acta Oncol. 2000;39(2):135-9.
16. • Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large cell lymphoma adjacent to breast implants: an indolent T cell lymphoproliferative disorder. Mod Pathol. 2008;21(4):455-63. [Case Reports]. Case series and one of the first papers to distinguish BIA-ALCL as a distinct pathological entity.
17. • Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32(9):1299-309. Large population-based study showing predominance of B cell lymphomas in patients with primary breast lymphoma without breast implants.
18. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement. Cancer. 2002;94(1):6-13.
19. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95(11):1977-9 [Case Reports Letter Review].
20. Kraemer DM, Tony HP, Gattenlohner S, Muller JG. Lymphoplasmacytic lymphoma in a patient with leaking silicone implant. Haematologica. 2004;89(4):ELT01 [Case Reports Letter Research Support, Non-U.S. Gov't].
21. Nichter LS, Mueller MA, Burns RG, Stallman JM. First report of nodal marginal zone B cell lymphoma associated with breast implants. Plast Reconstr Surg. 2012;129(3):576e-8 [Case Reports Editorial].
22. Cook PD, Osborne BM, Connor RL, Strauss JF. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol. 1995;19(6):712-7 [Case Reports].
23. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood. 1996;88(8):3124-8 [Case Reports Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
24. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005;23(19):4372-80 [Research Support, Non-U.S. Gov't].
25. Ferreri AJ, Govi S, Pileri SA, Savage KJ. ALK-negative. Anaplastic large cell lymphoma. Crit Rev Oncol Hematol. 2013;85(2):206-15.
26. Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96(12):3681-95 [Research Support, Non-U.S. Gov't Review].
27. Brody G, Deapen D, Gill P, Epstein A, Martin S, Elatra W. T cell non Hodgkins anaplastic large cell lymphoma associated with one style of breast implants. Proceedings of the 89th annual American society of plastic surgeons meeting; Mar 20-23; San Antonio, Texas, USA: The Westin La Cantera 2010.
28. Lechner MG, Megiel C, Church CH, Angell TE, Russell SM, Sevell RB, et al. Survival signals and targets for therapy in breast implant-associated ALK - anaplastic large cell lymphoma. Clin Cancer Res. 2012;18(17):4549-59 [Research Support, Non-U.S. Gov't].
29. • Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR, et al. Breast implant-associated, ALK-negative, T cell, anaplastic, large cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer. 2011;117(7):1478-89. [Research Support, Non-U.S. Gov't]. Outline of development of pre-clinical models based on a cell line taken from a case of BIA-ALCL with insights into the biology of the disease.
30. Maijers MC, Niessen FB. Prevalence of rupture in poly implant Prothese silicone breast implants, recalled from the European market in 2010. Plast Reconstr Surg. 2012;129(6):1372-8 [Comparative Study].
31. Keogh B. UK Department of Health; [updated 18/6/2012; cited 2013 1/2/2013]; NHS publication]. Available from: http://www.nhs.uk/conditions/ breast-implants/documents/PIP expert group final report.pdf.
32. Dieterich M, Stubert J, Stachs A, Radke A, Reimer T, Gerber B. Ruptured poly-implant protheses breast implant after aesthetic breast augmentation: diagnosis, case management, and histologic evaluation. Aesthet Plast Surg. 2013;37(1):91-4.
33. UK Department of Health; 2011 [cited 2013 1/2/2013]; NHS Publication]. Available from: http://www.nhs.uk/news/2011/12December/Pages/pip-breast- implants-france-cancer-case.aspx.
34. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma. 2009;50(5):831-3 [Case Reports Letter].
35. Aladily TN, Medeiros LJ, Alayed K, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a newly recognized entity that needs further refinement of its definition. Leuk Lymphoma. 2012;53(4):749-50 [Comment Letter].
36. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009;4:11.
37. Do V, Shifrin DA, Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg. 2010;76(9):1030-1 [Letter].
38. Farkash EA, Ferry JA, Harris NL, Hochberg EP, Takvorian RW, Zuckerman DS, et al. Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009;2(4):237-44.
39. Fritzsche FR, Pahl S, Petersen I, Burkhardt M, Dankof A, Dietel M, et al. Anaplastic large cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer - a case report. Virchows Arch. 2006;449(5):561-4 [Case Reports].
40. Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002;43(1):5.
41. Hanson SE, Gutowski KA. Primary T cell lymphoma associated with breast implant capsule. Plast Reconstr Surg. 2010;126(1):39e-41 [Case Reports Letter].
42. Keech Jr JA, Creech BJ. Anaplastic T cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100(2):554-5 [Case Reports Letter].
43. Shiyong Li AKL. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol. 2010;3(1):11.
44. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61(7):822-5 [Case Reports Review].
45. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Plast Reconstr Surg. 2006;118(s4):1.
46. Popplewell L, Thomas SH, Huang Q, Chang KL, Forman SJ. Primary anaplastic large cell lymphoma associated with breast implants. Leuk Lymphoma. 2011;52(8):1481-7 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
47. Smith TJ, Ramsaroop R. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast. 2012;21(1):102-4 [Case Reports].
48. Taylor KO, Webster HR, Prince HM. Anaplastic large cell lymphoma and breast implants: five Australian cases. Plast Reconstr Surg. 2012;129(4):610e-7 [Case Reports].
49. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003;127(3):e115-8 [Case Reports Review].
50. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 2008;32(8):1265-8 [Case Reports Review].
51. Carty MJ, Pribaz JJ, Antin JH, Volpicelli ER, Toomey CE, Farkash EA, et al. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg. 2011;128(3):112e-8 [Case Reports].
52. • Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012;36(7):1000-8. Largest published case series, with discussion of pathological features.
53. Kim B, Roth C, Young VL, Chung KC, van Busum K, Schnyer C, et al. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg. 2011;128(3):629-39 [Research Support, Non-U.S. Gov't Review].